Reframing obesity as a chronic disease: A turning point for Malaysia’s NCD strategy

11 Jun 2026

Share

Malaysia stands at a critical juncture in its public health trajectory, driven by rapid urbanization, demographic ageing, and lifestyle transitions that are reshaping national disease patterns.1 At the 2nd Malaysian Obesity Society (MYOS) National Obesity Scientific Conference (NOSC) 2026, Dr. Thahirahtul Asma’ Zakaria, Deputy Director of Non-Communicable Diseases, Disease Control Division, Ministry of Health (MoH), Malaysia, provided an overview of Malaysia’s evolving obesity landscape, highlighting its growing public health impact and the need for a more structured, system-level response.1 She also highlighted the key drivers of obesity, challenges in obesity management, and national strategies to address the growing burden of obesity and related non-communicable diseases (NCDs).1

Urbanization has shifted population behavior towards sedentary lifestyles and unhealthy dietary habits, while an aging population increases long-term care demand.1 This collectively accelerating NCDs burden, such as diabetes, cardiovascular disease, and chronic kidney disease, are closely interlinked with obesity.1 Dr. Asma highlighted that a transition from reactive treatment to proactive population health transformation is therefore urgently needed.1

The national burden of obesity underscores the urgency of this shift.1 Malaysia demonstrates a rising and concerning obesity burden, with 54.4% of adults overweight or obese under the World Health Organization (WHO) criteria and 70.1% under Asian cut-offs, alongside an increase in abdominal obesity from 45.4% in 2011 to 54.5% in 2023.2 These epidemiological signals reflect a significant and growing public health burden of Malaysia’s NCD landscape rather than a peripheral risk factor.1

Obesity is increasingly recognized as a complex, chronic disease associated with more than 200 complications, including cardiometabolic, hepatic, respiratory, and oncological conditions.3 It frequently clusters with other NCDs, acting as an upstream central driver of multimorbidity and worsening both morbidity and mortality outcomes.1 This translates into a substantial economic burden through healthcare expenditure and productivity losses, particularly presenteeism and premature mortality.4 Dr. Asma explained that obesity should therefore be understood as a chronic medical condition with significant multisystem health consequences at the population level rather than an isolated condition.1

Despite this burden, a key barrier remains the persistent misconception that obesity is driven primarily by willpower alone.1 In reality, weight regulation is governed by biological mechanisms, including hormonal adaptation, metabolic resistance to weight loss, and genetic susceptibility.1 It is further influenced by environmental drivers such as sedentary urban design, easy access to unhealthy foods, and reduced physical activity.1 This makes obesity fundamentally resistant to simplistic behavioral interventions.1 Effective management must therefore move beyond individual responsibility alone towards a structured, multi-level approach addressing both biological and environmental determinants.1

Long-term management of obesity requires a combination of interventions.1 Lifestyle modification remains the foundation, but must be delivered as structured and sustained programs encompassing diet, physical activity, sleep, and behavioral support.1 At the systems level, MoH has introduced behavioral insight strategies that reshape environments through nudges, default options, and environmental restructuring, alongside improving health literacy to support sustained behavioral change.1 Emerging pharmacotherapy and bariatric surgery serve as important adjuncts within a stepwise care pathway, with medications improving weight and cardiometabolic risk factors, and bariatric surgery remaining the most effective long-term option for clinically indicated patients with severe obesity.1

Malaysia’s national commitment to treating obesity as a chronic disease is operationalized through the Multidisciplinary Integrated Management of Obesity (MIMO) program.1 This structured, nationwide framework standardizes care from primary to tertiary settings, beginning with systematic screening and risk stratification, followed by strategic referral and patient enrollment.1 It incorporates multidisciplinary lifestyle interventions, enables targeted escalation to advanced therapies when indicated, and emphasizes measurable clinical and health system outcomes.1 Coupled with long-term follow-up and maintenance, this integrated pathway aims to deliver comprehensive obesity care in Malaysia while reducing overall healthcare costs.1

Moving forward, addressing obesity requires a whole-of-government and whole-of-society approach, involving coordinated action across urban planning, education, transport, and food regulation, as well as engagement of families, employers, schools, and communities.1 Dr. Asma stressed that this integrated strategy is pivotal in driving the transition towards a health system that empowers citizens to live longer, healthier lives through prevention and integration.1 It underpins the shift to a prevention-focused model, establishing seamless, integrated care pathways while fostering a more health-literate and empowered population.1 Importantly, this approach extends beyond weight management alone to safeguard the future health of the nation by reducing the long-term burden of NCDs.1

References

  1. Zakaria TA. Obesity is a chronic disease: Shifting perspectives and treatment paradigms in Malaysia. Presented at the 2nd Malaysian Obesity Society (MYOS) National Obesity Scientific Conference (NOSC) 2026; April 11-12, 2026.
  2. Institute for Public Health 2024. National Health and Morbidity Survey (NHMS) 2023: Non-communicable Diseases and Healthcare Demand – Key Findings. Available at: https://iku.nih.gov.my/images/nhms2023/key-findings-nhms-2023.pdf. Accessed May 16 2026.
  3. Yuen M, et al. Poster T‐P‐3166: A systematic review and evaluation of current evidence reveals 236 obesity‐associated disorders (ObAD). Presented at the Obesity Society Annual Meeting 2016; October 31-November 4, 2016.
  4. Okunogbe A, et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Global Health. 2022;7:e009773.

Login

Get access to our exclusive articles.